Open Access
Issue
BIO Web Conf.
Volume 30, 2021
II International Symposium “Innovations in Life Sciences” (ILS 2020)
Article Number 03003
Number of page(s) 3
Section Pharmaceutical Cluster as an Integration of Science, Education and Production
DOI https://doi.org/10.1051/bioconf/20213003003
Published online 22 April 2021
  • H. Döhner, D.J. Weisdorf, C.D. Bloomfield, N. Engl. J. Med.,. 373, p. 1136-1152 (2015) [Google Scholar]
  • F. L. Mabrey, K. M. Gardner, K. S. Dorcy, A. Perdue, H. A. Smith [et al.], Blood Adv., 4, 611–616 (2020) [Google Scholar]
  • Leunis, H.M. Blommestein, P.C. Huijgens, N.M. Blijlevens, M. Jongen-Lavrencic, C.A. Uyl-de Groo, Leuk. Res., 37, 245-250 (2013) [Google Scholar]
  • H. Döhner, E.H. Estey, S. Amadori, [et al.], Blood, 115, p. 453-474 (2010) [Google Scholar]
  • F.R. Appelbaum, H. Gundacker, D.R. Head, [et al.], “Age and acute myeloid leukemia,” Blood., 107, p. 3481-3485 (2006) [Google Scholar]
  • F. Efficace, G. Kemmler, M. Vignetti, F. Mandelli, S. Molica, B. Holzner, Eur. J. Cancer, 44, p. 14971506 9 (2008) [Google Scholar]
  • J.-Y. Cahn, M. Labopin, J. Sierra, D. Blaise, J. Reiffers, A. Ferrant [et al.], British Journal of Haematology, 110, p. 308-314 (2000) [Google Scholar]
  • S.-Ch. Heng, M. A. Slavin, D. Al-Badriyeh, S. Kirsa, J. F. Seymour [et al.], J. Antimicrob. Chemother., 68, 1669-1678 (2013) [Google Scholar]
  • G.J. Roboz, Novel approaches to the treatment of acute myeloid leukemia,: Hematology (Eduacation program book, San Diego), 43-50 (2011) [Google Scholar]
  • R.B. Walter, L.R. Taylor, K.M. Gardner, K.S. Dorcy, J.E. Vaughn, E.H. Estey, Clin Adv Hematol Oncol., 11. 571-577, (2013). [Google Scholar]
  • A.M. Stalfelt, H. Brodin, B. Wadman, Leuk. Res., 18, 783-790 (1994) [Google Scholar]
  • M.L. Savoie, T.J. Nevil, K.W. Song [et al.], Ann Oncol., 17, 763-768, (2006) [Google Scholar]
  • E.N. Parovichnikova, G.A. Klyasova, A.N. Sokolov [et al.], Therapeutic archive, 7, 10-15, (2012). [Google Scholar]
  • H.F. Fernandez, Z. Sun, X. Yao [et al.], N. Engl. J. Med., 361, 1249-1259, (2009) [Google Scholar]
  • T. Møller, O.J. Nielsen, P. Welinder [et al.], Eur. J Haematol., 84, 316-322 (2010) [Google Scholar]
  • O.A. Cornely, A. Bohme, D. Buchheidt [et al.], Haematologica, 94, 113–122, (2009) [Google Scholar]
  • T. Buchner, W.E. Berdel, C. Schoch [et al.], J. Clin. Oncol., 24, 2480-2489, (2006) [Google Scholar]
  • R.B. Walter, M. Othus, G. Borthakur [et al.], J. Clin. Oncol., 33, p. 4417-4423 (2011) [Google Scholar]
  • J. Crawford, D.C. Dale, N.M. Kuderer [et al.], J. Natl. Compr. Canc. Netw., 6, 109-118. (2008) [Google Scholar]
  • I.V. Spichak, Y.S. Dereglazova, A.S. Spichak [et al.], ” Drug Invention Today, 11, 2395-2399, (2019) [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.